These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 13721922)
21. The mode of action of phenylindanedione. WALKER W; HUNTER RB J Clin Pathol; 1954 Aug; 7(3):249-51. PubMed ID: 13192203 [No Abstract] [Full Text] [Related]
22. [Anticoagulant and hemostatic therapy in obstetrics and gynecology. I. Phenylindanedione]. STURA L; CRAVAREZZA F Quad Clin Ostet Ginecol; 1955 Jul; 10(7):409-26. PubMed ID: 13266979 [No Abstract] [Full Text] [Related]
23. [Comparative influence of coumadine and pindione on the prothrombin levels and coagulability index]. BUREAU DU COLOMBIER H Angeiologie; 1962; 14():25-7. PubMed ID: 13874764 [No Abstract] [Full Text] [Related]
24. A one stage method for the assay of antihemophilic factor B (AHF B) with a comment on the antihemophilic factor B (AHF B) concentration in phenylindanedione (PID) therapy. STAPP WF Scand J Clin Lab Invest; 1958; 10(2):169-76. PubMed ID: 13602673 [No Abstract] [Full Text] [Related]
26. LABORATORY CONTROL OF ANTICOAGULANT THERAPY. LAU KS; SINGH N Med J Malaya; 1963 Dec; 18():107-15. PubMed ID: 14117278 [No Abstract] [Full Text] [Related]
27. Clinical use of a new anticoagulant, phenylindanedione; report of 400 cases. BLAUSTEIN A; SHNAYERSON N; WALLACH R Am J Med; 1953 Jun; 14(6):704-6. PubMed ID: 13057880 [No Abstract] [Full Text] [Related]
28. Phenylindandione: a new oral anticoagulant. COON WW; DUFF IF; HODGSON PE; DENNIS EW Med Bull (Ann Arbor); 1953 Apr; 19(4):77-9. PubMed ID: 13049722 [No Abstract] [Full Text] [Related]
31. Heparin resistance determined by the heparin tolerance test in patients treated with phenylindanedione before, during, and after operation. GORMSEN J; HAXHOLDT BF Acta Chir Scand; 1961; 121():367-76. PubMed ID: 13707283 [No Abstract] [Full Text] [Related]
32. EFFECT OF SUDDEN WITHDRAWAL OF LONG-TERM ANTICOAGULANT THERAPY ON THE HEPARIN RESISTANCE AND PLASMA FIBRINOGEN LEVEL. COTTON RC; WADE EG Clin Sci; 1964 Apr; 26():337-43. PubMed ID: 14162427 [No Abstract] [Full Text] [Related]
33. [Blood coagulation controls in ambulant use of anticoagulants]. Gross R; Voss D Thromb Diath Haemorrh Suppl; 1964; 12():27-32. PubMed ID: 5882977 [No Abstract] [Full Text] [Related]
34. [Anticoagulant treatment with fluindione. Relation between the decrease of vitamin K-dependent factors and blood fluindione]. Roncato M; Billaud-Mesguich E; Fiessinger JN; Vitoux JF; Aiach M; Alexandre JM Therapie; 1986; 41(3):203-6. PubMed ID: 3750259 [No Abstract] [Full Text] [Related]
36. Control of anticoagulant therapy. A comparison of the thrombotest, the prothrombin-proconvertin method, and the prothrombin time. FICHERA C Acta Med Scand; 1962 Sep; 172():363-7. PubMed ID: 13945019 [No Abstract] [Full Text] [Related]
37. THE SYMPTOMATIC EFFECT OF ANTICOAGULANT THERAPY IN DEFIBRINATION SYNDROME ASSOCIATED WITH DEMONSTRABLE FIBRIN IN PLASMA: A CASE REPORT. GODAL HC; ABILDGAARD U Acta Med Scand; 1963 Sep; 174():311-4. PubMed ID: 14058757 [No Abstract] [Full Text] [Related]
38. [The conduct of anticoagulant therapy]. Larcan A; Gilgenkrantz JM; Streiff F; Calamai N Presse Med (1893); 1968 Feb; 76(10):457-9. PubMed ID: 5639856 [No Abstract] [Full Text] [Related]
39. ADMINISTRATION AND CONTROL OF ANTICOAGULANT TREATMENT. POLLER L Manch Med Gaz; 1964; 43():8-11. PubMed ID: 14125255 [No Abstract] [Full Text] [Related]
40. Tolerance to phenindione of patients with different thromboembolic disorders. Nour-Eldin F; Lewis FJ Acta Haematol; 1964 Dec; 32(6):338-47. PubMed ID: 5005471 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]